|1.||Holst, Jens J: 42 articles (09/2015 - 03/2002)|
|2.||Knop, Filip K: 21 articles (09/2015 - 01/2008)|
|3.||Cryer, Philip E: 20 articles (07/2014 - 03/2002)|
|4.||Holst, J J: 19 articles (10/2015 - 01/2000)|
|5.||Vilsbøll, Tina: 17 articles (09/2015 - 01/2008)|
|6.||Ahrén, Bo: 16 articles (10/2015 - 01/2002)|
|7.||Davis, Stephen N: 15 articles (09/2015 - 05/2002)|
|8.||Drucker, Daniel J: 15 articles (06/2015 - 07/2002)|
|9.||Sherwin, Robert S: 13 articles (03/2014 - 03/2003)|
|10.||Chan, Owen: 12 articles (10/2015 - 06/2002)|
|1.||Hypoglycemia (Reactive Hypoglycemia)
10/01/2002 - "Glucagon infusions appear to be beneficial for problematic neonatal hypoglycemia of different causes."
01/01/1992 - "During hypoglycemia, a significant rise of the plasma glucagon level was found only in the low-dose test (188 +/- 29 vs. 237 +/- 37 ng/L, P less than 0.05), and the incremental area under the glucagon curve was significantly greater in the low-dose than in the high-dose test (140 +/- 19 vs. -22.7 +/- 34 ng/L.h-1, P less than 0.005). "
11/01/2014 - "Glucagon delivery in closed-loop control of type 1 diabetes is effective in minimizing hypoglycemia. "
09/01/2012 - "Glucagon seemed mostly effective in preventing hypoglycemia. "
04/01/1991 - "Glucagon is safe and effective therapy for hypoglycemia in the prehospital setting."
07/01/1997 - "Glucagon secretion was less suppressed in the early part of the study in IPx, which may have contributed to the excessive hyperglycemia. "
10/01/1982 - "The aim of the present study was to determine the importance of hyperglycemia in the "downregulation" of the action of glucagon. "
10/13/1975 - "These studies indicate that excessive glucagon secretion participates in the genesis of diabetic postprandial hyperglycemia. "
11/01/2015 - "The loss of inhibition of glucagon secretion exacerbates hyperglycemia in type 1 and 2 diabetes. "
08/01/2015 - "Short-term diabetic hyperglycemia suppresses celiac ganglia neurotransmission, thereby impairing sympathetically mediated glucagon responses."
06/01/2007 - "Further studies are needed to identify the link between glucagon, insulin resistance and hemostasis."
01/01/2015 - "We suggest that the glucagon-cAMP-GSH axis is a potential therapeutic target to address insulin resistance in pathological conditions. "
01/01/2015 - "Acute glucagon induces postprandial peripheral insulin resistance."
01/01/2013 - "Peripheral insulin resistance in type 1 diabetes may be related to a paradoxical postprandial glucagon increase. "
09/01/2010 - "These results indicate that alpha-cells exposed to palmitate show insulin resistance of the IRS-1/PI3K/Akt pathway that likely controls glucagon secretion. "
07/01/1986 - "In each case serum glucagon levels were high and a pancreatic tumor was found, with complete remission of symptoms in cases 1 and 3 after resection; case 2 refused surgery and has died. "
08/01/1989 - "Immunohistochemical and ultrastructural examinations are particularly helpful in defining the tumor cell nature (alpha-2 islet cell) and the peptide content (glucagon). "
01/01/2011 - "In this study, we analyzed 404 P-NENs to gain information about the relative frequency of grossly cystic P-NENs and their association with glucagon production by the tumor cells. "
11/01/2007 - "Plasma glucagon levels were reduced to <50 pg/mL postoperatively, and scintigraphic study at 4-month follow-up showed no residual uptake at the previous tumor site or elsewhere. "
04/01/2005 - "In this study, we tested whether the catecholamine secretory response to glucagon was present in bovine chromaffin cells or exclusive to the tumor cells. "
|5.||Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/01/1993 - "The present study suggests that circulatory GH and glucagon play a contributory role in the renal haemodynamic changes in type 1 diabetes mellitus."
07/01/2015 - "The progress is promising, but major questions remain, including unravelling the mechanism of loss of glucagon counterregulation in type 1 diabetes mellitus and how best to manipulate glucagon to achieve more efficient and safer glycaemic control."
11/01/2013 - "Pharmacokinetics modeling of exogenous glucagon in type 1 diabetes mellitus patients."
09/01/2013 - "Glucagon underutilized among type 1 diabetes mellitus patients in Japan."
12/01/2009 - "Mice with autoimmune diabetes had an impaired glucagon response to sympathetic nerve activation, whereas those with non-autoimmune diabetes did not. "
|6.||Blood Glucose (Blood Sugar)
|7.||Glucagon-Like Peptide 1 (GLP 1)
|10.||Growth Hormone (Somatotropin)
|3.||Transplantation (Transplant Recipients)